{"celex_id": "32005R0869", "uri": "http://publications.europa.eu/resource/cellar/9fbfb89f-78b6-4833-b7df-d084c25b867d", "type": "Regulation", "concepts": ["1594", "2479", "2735", "2737", "2773", "5734"], "title": "Commission Regulation (EC) No\u00a0869/2005 of 8 June 2005 amending Annexes I and II to Council Regulation (EEC) No\u00a02377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards ivermectin and carprofen Text with EEA relevance\n", "header": "9.6.2005 EN Official Journal of the European Union L 145/19\nCOMMISSION REGULATION (EC) No 869/2005\nof 8 June 2005\namending Annexes I and II to Council Regulation (EEC) No 2377/90 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin as regards ivermectin and carprofen\n(Text with EEA relevance)\nTHE COMMISSION OF THE EUROPEAN COMMUNITIES", "recitals": ",\nHaving regard to the Treaty establishing the European Community,\nHaving regard to Council Regulation (EEC) No 2377/90 of 26 June 1990 laying down a Community procedure for the establishment of maximum residue limits of veterinary medicinal products in foodstuffs of animal origin\u00a0(1), and in particular Articles 2 and 3 thereof,\nHaving regard to the opinions of the European Medicines Agency formulated by the Committee for Medicinal Products for Veterinary Use,\nWhereas:\n(1) All pharmacologically active substances which are used within the Community in veterinary medicinal products intended for administration to food-producing animals should be evaluated in accordance with Regulation (EEC) No 2377/90.\n(2) Ivermectin has been included in Annex I to Regulation (EEC) No 2377/90 for bovine, porcine, ovine and Equidae for liver and fat and for deer including reindeer for liver, fat, muscle and kidney. That entry should be modified and extended to all mammalian food producing species excluding animals from which milk is produced for human consumption.\n(3) Carprofen has been included in Annex I to Regulation (EEC) No 2377/90 with carprofen as marker residue for bovine and Equidae for muscle, fat, liver and kidney excluding bovine from which milk is produced for human consumption. That marker residue should be replaced by the sum of carprofen and carprofen glucuronide conjugate. Carprofen should be included in Annex II to that Regulation for bovine milk only.\n(4) Regulation (EEC) No 2377/90 should be amended accordingly.\n(5) An adequate period should be allowed before the applicability of this Regulation in order to enable Member States to make any adjustment which may be necessary in the light of this Regulation to the marketing authorisations granted in accordance with Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products\u00a0(2).\n(6) The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,", "main_body": ["Annexes I and II to Regulation (EEC) No 2377/90 are amended in accordance with the Annex to this Regulation.", "This Regulation shall enter into force on the third day following its publication in the Official Journal of the European Union.\nIt shall apply from 8 August 2005.\nThis Regulation shall be binding in its entirety and directly applicable in all Member States."], "attachments": "Done at Brussels, 8 June 2005.\nFor the Commission\nG\u00fcnter VERHEUGEN\nVice-President\n(1)\u00a0\u00a0OJ L 224, 18.8.1990, p. 1. Regulation as last amended by Commission Regulation (EC) No 712/2005 (OJ L 120, 12.5.2005, p. 3).\n(2)\u00a0\u00a0OJ L 311, 28.11.2001, p. 1. Directive as last amended by Directive 2004/28/EC (OJ L 136, 30.4.2004, p. 58).\nANNEX\nA.\u00a0\u00a0\u00a0The following substance(s) is(are) inserted in Annex I to Regulation (EEC) No 2377/90\n2.\u00a0\u00a0\u00a0Antiparasitic agents\n2.3.\u00a0\u00a0\u00a0Agents acting against endo- and ectoparasites\n2.3.1.\u00a0\u00a0\u00a0Avermectins\nPharmacologically active substance(s) Marker residue Animal species MRLs Target tissues\n\u2018Ivermectin 22,23-Dihydro-avermectin B1a All mammalian food-producing species\u00a0(1) 100\u00a0\u03bcg/kg Fat\n100\u00a0\u03bcg/kg Liver\n30\u00a0\u03bcg/kg Kidney\n4.\u00a0\u00a0\u00a0Anti-inflammatory agents\n4.1.\u00a0\u00a0\u00a0Nonsteroidal anti-inflammatory agents\n4.1.1.\u00a0\u00a0\u00a0Arylpropionic acid derivative\nPharmacologically active substance(s) Marker residue Animal species MRLs Target tissues\n\u2018Carprofen Sum of carprofen and carprofen glucuronide conjugate Bovine, equidae 500\u00a0\u03bcg/kg Muscle\n1\u00a0000\u00a0\u03bcg/kg Fat\n1\u00a0000\u00a0\u03bcg/kg Liver\n1\u00a0000\u00a0\u03bcg/kg Kidney\u2019\nB.\u00a0\u00a0\u00a0The following substance(s) is(are) inserted in Annex II to Regulation (EEC) No 2377/90\n8.\u00a0\u00a0\u00a0Anti-inflammatory agents\nPharmacologically active substance(s) Animal species\n\u2018Carprofen Bovine\u00a0(2)\n(1)\u00a0\u00a0Not for use in animals from which milk is produced for human consumption.\u2019\n(2)\u00a0\u00a0For bovine milk only.\u2019"}